Tech Company Financing Transactions
iQure Pharma Funding Round
iQure Pharma, based in Wilmington, secured $1.2 million from OKG Capital and Ventura BioMed Investors.
Transaction Overview
Company Name
Announced On
10/23/2023
Transaction Type
Venture Equity
Amount
$1,200,000
Round
Undisclosed
Investors
Proceeds Purpose
iQure Pharma Inc. (iQure), a CNS company dedicated to the development of new epilepsy and pain management therapeutics, has completed the first closing of its latest round of funding.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
251 Little Falls Dr
Wilmington, DE 19808
USA
Wilmington, DE 19808
USA
Phone
Undisclosed
Website
Email Address
Overview
iQure Pharma is a US-based, global biotech company created by entrepreneurs and former Pharma managers focused on the development of new therapeutics for neuropathic pain, an indication with a high unmet medical need.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Pawel Zolnierczyk
Chief Financial Officer
Anna Rzewuska
Chief Operating Officer
Henk Wilde
Browse more venture capital transactions:
Prev: 10/23/2023: Copresence venture capital transaction
Next: 10/23/2023: Wareclouds venture capital transaction
Share this article
News on VC Transactions
We do our best to report on tech company VC transactions. VC investment data records reported here are derived from a variety of public sources. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs